Use of digoxin for heart failure and atrial fibrillation in elderly patients

American Journal Geriatric Pharmacotherapy

Volumn 8, Issue 5, 2010, Pages 419-427

  Cheng, Judy W M ^a,b   Rybak, Iwona ^b  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

atrial fibrillation; digoxin; geriatrics; heart failure

Indexed keywords

AMIODARONE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLARITHROMYCIN; CYCLOSPORIN; DIGITALIS; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROMYCIN; ITRACONAZOLE; KETOCONAZOLE; PLACEBO; PROPAFENONE; QUINIDINE; VERAPAMIL;

AREA UNDER THE CURVE; ARTICLE; DIGOXIN BLOOD LEVEL; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE TITRATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TRANSFORMATION; DRUG USE; DRUG WITHDRAWAL; GERIATRIC DISORDER; HEART ARRHYTHMIA; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HOSPITALIZATION; HUMAN; LOADING DRUG DOSE; NAUSEA; PREVALENCE; PRIORITY JOURNAL; SEDENTARY LIFESTYLE; VISUAL DISORDER; VOMITING;

AGED; AGED, 80 AND OVER; AGING; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIOTONIC AGENTS; DIGOXIN; HEART FAILURE; HUMANS;

EID: 79951989907     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2010.10.001     Document Type: Article

References (45)

1. The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
2. SA Hunt, WT Abraham, MH Chin for the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, International Society for Heart and Lung Transplantation 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults Circulation 119 2009 e391 e479
3. WS Aronow Optimal management of older patients with atrial fibrillation Drugs Aging 4 1994 184 193
4. V Fuster, LE Rydn, DS Cannom for the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association, Heart Rhythm Society ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society [published correction appears in Circulation. 2007;116:e138 ] Circulation 114 2006 e257e354
5. http://circ.ahajournals.org/cgi/content/full/114/7/e257 January 2, 2009 Accessed
6. EJ Eichhorn, and M Gheorghiade Digoxin-new perspective on an old drug N Engl J Med 347 2002 1394 1395
7. D Lloyd-Jones, RJ Adams, TM Brown for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics 2010 update: A report from the American Heart Association Circulation 121 2010 e46 e215
8. http://circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.109.192667 January 2, 2010 Accessed
9. B Miaiaszek, GA Heckman, and F Merali Digoxin prescribing for heart failure in elderly residents of long-term care facilities Can J Cardiol 21 2005 281 286 (Pubitemid 40542370)
10. D Fishkind, BE Paris, and WS Aronow Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice J Am Geriatr Soc 45 1997 809 812 (Pubitemid 27289926)
11. MW Rich, F McSherry, WO Williford, S Yusuf for the Digitalis Investigation Group Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: The DIG study J Am Coll Cardiol 38 2001 806 813 (Pubitemid 32835757)
12. IF Adams Jr, M Gheorghiade, and BF Uretsky Clinical benefits of low serum digoxin concentrations in heart failure J Am Coll Cardiol 39 2002 946 953 (Pubitemid 34234114)
13. SS Rathore, JP Curtis, and Y Wang Association of serum digoxin concentration and outcomes in patients with heart failure JAMA 289 2003 871 878 (Pubitemid 37430346)
14. JR Kuop, DJ Greenblatt, and WJ Jusko Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses J Pharmacokinet Biopharm 3 1975 181 192
15. WS Aronow Appropriate use of digoxin in treating older nursing home patients with heart failure J Am Med Dir Assoc 7 2006 604 606 (Pubitemid 44767126)
16. DS Budnitz, N Shehab, SR Kegler, and CL Richards Medication use leading to emergency department visits for adverse drug events in older adults Ann Intern Med 147 2007 755 765 (Pubitemid 351664440)
17. DE Forman, D Coletta, and D Kenny Clinical issues related to discontinuing digoxin therapy in elderly nursing home patients Arch Intern Med 151 1991 2194 2198
18. WS Aronow Prevalence of appropriate and inappropriate indications for use of digoxin in older patients at the time of admission to a nursing home J Am Geriatr Soc 44 1996 588 590 (Pubitemid 26137243)
19. RW Jelliffe, and G Brooker A nomogram for digoxin therapy Am J Med 57 1974 63 68
20. M Gheorghiade, and E Braunwald Reconsidering the role for digoxin in the management of acute heart failure syndromes JAMA 302 2009 2146 2147
21. B Cusack, J Horgan, and JG Kelly Pharmacokinetics of digoxin in the elderly Br J Clin Pharmacol 6 1978 439P 440P (Pubitemid 9033588)
22. DM Schreck, AR Rivera, and VJ Tricarico Emergency management of atrial fibrillation and flutter: Intravenous diltiazem versus intravenous digoxin Ann Emerg Med 29 1997 135 140 (Pubitemid 27030029)
23. R Farshi, D Kistner, and JS Sarma Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: A crossover open-label study of five drug regimens J Am Coll Cardiol 33 1999 304 310 (Pubitemid 29234189)
24. AP Passmore, and GD Johnston Digoxin toxicity in the aged. Characteristics and avoiding the problem Drugs Aging 1 1991 364 379
25. P Tsang, and B Gerson Understanding digoxin in the elderly patient Clin Lab Med 10 1990 479 492
26. JH Caldwell, JF Martin, S Dutta, and NJ Greenberger Intestinal absorption of digoxin-3H in the rat Am J Physiol 217 1969 1747 1751
27. RJ White, DA Chamberlain, M Howard, and TW Smith Plasma concentrations of digoxin after oral administration in the fasting and postprandial state Br Med J 1 1971 380 381
28. JR Saha, VP Butler Jr, HC Neu, and J Lindenbaum Digoxininactivating bacteria: Identification in human gut flora Science 220 1983 325 327 (Pubitemid 13118491)
29. AD Mooradian Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations Clin Pharmacokinet 15 1988 165 179
30. JE Doherty, WH Perkins, and WJ Flanigan The distribution and concentration of tritiated digoxin in human tissues Ann Intern Med 66 1967 116 124
31. DJ Summer, and AJ Russell Digoxin pharmacokinetics: Multicompartmental analysis and its clinical implications Br J Clin Pharmacol 3 1976 221 229
32. MH Gault, LL Longerich, and JC Loo Digoxin biotransformation Clin Pharmacol Ther 35 1984 74 82 (Pubitemid 14179533)
33. IA de Lannoy, and M Silverman The MDRI gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin Biochem Biophys Res Commun 189 1992 551 557 (Pubitemid 23030076)
34. JK Aronson, and M Hardman ABC of monitoring drug therapy. Digoxin BMJ 305 1992 1149 1152
35. R Bressler, and JJ Bahl Principles of drug therapy for the elderly patient Mayo Clin Proc 78 2003 1564 1577 (Pubitemid 37475642)
36. AD Bender Effect of age on intestinal absorption: Implications for drug absorption in the elderly J Am Geriatr Soc 16 1968 1331 1339
37. MC Geokas, and BJ Haveback The aging gastrointestinal tract Am J Surg 117 1969 881 892
38. JW Cheng, SL Charland, and LM Shaw Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacoldnetics by fluorescence polarization immunoassay Pharmacotherapy 17 1997 584 590 (Pubitemid 27227565)
39. A Hmmerlein, H Derendorf, and DT Lowenthal Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications Clin Pharmacokinet 35 1998 49 64 (Pubitemid 28318962)
40. BF Uretsky, JB Young, and FE Shahidi Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial. PROVED Investigative Group J Am Coll Cardiol 22 1993 955 962 (Pubitemid 23285742)
41. M Packer, M Gheorghiade, and JB Young Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting- enzyme inhibitors. RADIANCE Study N Engl J Med 329 1993 1 7 (Pubitemid 23182871)
42. HJ Priebe The aged cardiovascular risk patient Br J Anaesth 85 2000 763 778
43. Lanoxin® [prescribing information] 2009 GlaxoSmithICine Research Triangle Park, NC
44. M Gheorghiade, DJ van Veldhuisen, and WS Colucci Contemporary use of digoxin in the management of cardiovascular disorders Circulation 113 2006 2556 2564 (Pubitemid 43948035)
45. CA Sanoski Atrial and ventricular arrhythmias: Evolving practices JW Cheng, Pharmacotherapy SelfAssessment Program 7th ed 2010 American College of Clinical Pharmacy Kansas City, Kan 125 146 Book 1, Cardiology